While CJC-1295/Ipamorelin offers a synergistic approach with intermittent and sustained GH release, potentially benefiting muscle growth and fat loss, Tesamorelin is primarily prescribed for HIV-related lipodystrophy and has a more targeted effect on reducing visceral fat
Yes, and the choice of peptide depends on the primary mechanism driving a persons skin concerns
FDA approval Both medications are approved by the U.S
Throughout your journey, your healthcare provider will closely monitor your progress, making adjustments as needed to make sure you receive the support and care necessary to achieve lasting weight loss success
Weight Loss Beyond diabetes management, tirzepatide is also effective for weight loss
Lancet 397 , 22842303 (2021)